FLOW CYTOMETRIC VS MORPHOLOGIC ASSESSMENT OF REMISSION IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP (COG)

Minimal residual disease (MRD) after initial therapy is integral to risk stratification in B- and T-precursor acute lymphoblastic leukemia (B-ALL, T-ALL). While MRD determines depth of remission, remission remains defined by morphology. We determined the outcomes of children with discordant assessme...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Leukemia
Autores principales: Gupta, Sumit, Devidas, Meenakshi, Loh, Mignon L., Raetz, Elizabeth A., Chen, Si, Wang, Cindy, Brown, Patrick, Carroll, Andrew J., Heerema, Nyla A., Gastier-Foster, Julie M., Dunsmore, Kimberly P., Larsen, Eric C., Maloney, Kelly W., Mattano, Leonard A., Winter, Stuart S., Winick, Naomi J., Carroll, William L., Hunger, Stephen P., Borowitz, Michael J., Wood, Brent L.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5992047/
https://ncbi.nlm.nih.gov/pubmed/29472723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-018-0039-7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares